InsiderTrades

Alder Matthias

SEC CIK 1370820 · EDGAR

Buying vs selling by month open-market trades, last 34 months, GANX
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
GANXGain Therapeutics, Inc.CEO, Dir 21.1K — $5,057 82023-07-012024-03-26

Most active insiders at GANX, 12 months

#InsiderTitleBoughtSold
No open-market trades in the last year.

Alder Matthias made no open-market trades at GANX in the last 12 months.

Transactions 8

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-28 2024-03-26 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir F - Tax $4.06 -6,085 21.1K -22% -$24.7K
DM 2024-03-28 2024-03-26 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir M - OptEx — +20.2K 27.2K +288% —
D 2023-12-22 2023-12-20 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir M - OptEx — +637 5,492 +13% —
D 2023-12-22 2023-12-21 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir S - Sale+OE $2.46 -206 5,286 -4% -$506.76
2023-12-14 2023-12-07 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir S - Sale $2.50 -1,820 4,855 -27% -$4,550
D 2023-10-03 2023-10-01 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir M - OptEx — +825 6,675 +14% —
D 2023-09-22 2023-09-20 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir M - OptEx — +2,550 5,850 +77% —
D 2023-07-05 2023-07-01 GANX Gain Therapeutics, Inc. Alder Matthias CEO, Dir M - OptEx — +3,300 3,300 New —

Purchase Sale Sale after option exercise All abbreviations